Shanghai Laishi: human thrombin has been approved for drug supplement application
Financial Associated Press, December 15 (Xinhua) - Shanghai Laishi announced that the company's human thrombin obtained the notice of approval of drug supplementary application.
This text is a result of machine translation.
Related companies：
In-depth
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Apr 02, 2022 05:34 PM
· Technology
China network security industry innovation and development alliance was officially established
Industrials
Haier Egypt Ecological Park Officially Opens
On May 2nd, local time, the Haier Egypt Eco-Park in 10th of Ramadan City, Egypt, held its opening ceremony. The eco-park, which is developed in two phases, covers an area of 200,000 square meters and involves an investment of $135 million. It is designed to have a total production capacity of over 1.5 million units and will create 3,000 jobs.
May 10, 2024 01:57 PM
Briefing Feb 17, 2022 07:29 PM
· Technology
Chinese mission to the European Union: express strong dissatisfaction and firm opposition to the European Parliament's arbitrary discussion of China's internal affairs
Briefing Feb 17, 2022 08:29 AM
· Technology
CITIC Securities: metauniverse is a future trend that cannot be underestimated, but it is still in the early stage of concept and marketing
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
An Initial Assessment of Market Entry Opportunities in Central Asia
Updated 39 mins ago
Insight
In-depth